Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. AZN
6. ROIV
7. AAPL
8. HOOD
9. QCOM
10. ACN

Go back to Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.19 -0.03 (0.29%)
Previous Close $10.22    52 Week High $9.23 
Open $10.10    52 Week Low $1.16 
Day High $10.36    P/E N/A 
Day Low $9.75    EPS $-0.30 
Volume 4,129,314